Institution Directory

Clinical trials at Northwestern Medicine

Sites in Chicago, IL

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 12:22 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1124

Shown on this page

Current sort

Live official records

Conditions: Non-muscle Invasive Bladder Cancer
Interventions: BCG (50mg/instillation) + N-803 (400 μg/instillation), BCG (50mg/instillation); Biological
Lead sponsor: ImmunityBio, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 369 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2039
U.S. locations: 72
States / cities: Birmingham, Alabama • Anchorage, Alaska • Phoenix, Arizona + 60 more

Conditions: Unruptured Wide-neck Aneurysms
Interventions: Citadel Embolization Device; Device
Lead sponsor: Stryker Neurovascular; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 25
States / cities: Los Angeles, California • San Francisco, California • Walnut Creek, California + 18 more

Conditions: Embolization, Vascular Tumor, Renal Angiomyolipoma, Renal Cell Carcinoma, Bone Tumor, Portal Vein Embolization
Interventions: GPX® Embolic Device; Device
Lead sponsor: Fluidx Medical Technology, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 15
States / cities: La Jolla, California • Aurora, Colorado • Chicago, Illinois + 11 more

Conditions: Extensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype, Lung Small Cell Carcinoma, I Subtype, Lung Small Cell Carcinoma, N Subtype, Lung Small Cell Carcinoma, P Subtype
Interventions: Biospecimen Collection, Ceralasertib, Computed Tomography, Durvalumab, Etoposide, Magnetic Resonance Imaging, Monalizumab, Platinum Compound, Positron Emission Tomography, Saruparib, Thoracic Radiation Therapy; Procedure · Drug · Biological + 1 more
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 148
States / cities: Loma Linda, California • Rancho Mirage, California • Sacramento, California + 118 more

Conditions: Insomnia
Interventions: Light Exposure, Placebo; Other
Lead sponsor: Northwestern University; Other
Eligibility: 55 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Relapsed or Resistant Acute Leukaemias
Interventions: LBS-007; Drug
Lead sponsor: Lin BioScience, Inc; Industry
Eligibility: 18 Years to 120 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 5
States / cities: Tampa, Florida • Chicago, Illinois • Fairway, Kansas + 2 more

Conditions: Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Interventions: NTLA-2001, Placebo; Biological · Drug
Lead sponsor: Intellia Therapeutics; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 38
States / cities: Tucson, Arizona • Los Angeles, California • Palo Alto, California + 29 more

Conditions: ESRD (End-Stage Renal Disease), Kidney Transplantation, Xenotransplantation
Interventions: 10 GE Xenokidney; Biological
Lead sponsor: United Therapeutics; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2075
U.S. locations: 2
States / cities: Chicago, Illinois • New York, New York

Conditions: Phenylketonuria (PKU)
Interventions: Pegvaliase; Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: Not listed
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2033
U.S. locations: 12
States / cities: Aurora, Colorado • Atlanta, Georgia • Chicago, Illinois + 9 more

Conditions: Pressure Sore
Interventions: V.A.C.Ulta™ Negative Pressure Wound Therapy System, Standard of Care (Wet-to-dry dressings); Device · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Clinically Significant Prostate Cancer
Interventions: Not listed
Lead sponsor: Xijing Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 1,700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Transplant, Heart, Magnetic Resonance Imaging
Interventions: MRI Sequencing, MRI Testing (pediatric), MRI Testing; Diagnostic Test
Lead sponsor: Northwestern University; Other
Eligibility: Not listed
Enrollment: 247 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2030
U.S. locations: 2
States / cities: Chicago, Illinois

About this Northwestern Medicine institution page

What this page lists: ClinicalTrials.gov records that list Northwestern Medicine in Chicago, IL as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Northwestern Medicine

Filter and sort this campus

Live official records

A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

Citadel Embolization Device Study

Evaluation of a Simple-Prep Controlled Embolic

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Noradrenergic Dysregulation, Sleep and Cognition in Older Adults With Insomnia

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

NPWTi on Closure of Chronic Pressure Sores

Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer

Heart Transplantation - Renewal

About this Northwestern Medicine institution page